The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Finasteride Market Research Report 2025

Global Finasteride Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1451965

No of Pages : 96

Synopsis

Finasteride is a prescription drug in tablet form.
The global Finasteride market was valued at US$ 118.4 million in 2023 and is anticipated to reach US$ 155.9 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.

North American market for Finasteride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Finasteride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Finasteride include Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals and Henan Topfond, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Finasteride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Finasteride.

Report Scope

The Finasteride market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Finasteride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Merck
  • Actavis
  • Sandoz
  • Teva Pharmaceuticals
  • Cipla
  • RelonChem
  • Dr. Reddy
  • Accord Pharmaceuticals
  • Henan Topfond
  • Zhejiang CONBA Pharmaceutical
  • Shandong Renhetang Pharmaceutical
  • Guangdong Eashu Pharmacetical

Segment by Type

  • 1mg Tablet
  • 5mg Tablet

Segment by Application

  • Medical Uses
  • Application 2

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Finasteride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Finasteride Market Overview
1.1 Product Overview and Scope of Finasteride
1.2 Finasteride Segment by Type
1.2.1 Global Finasteride Market Value Comparison by Type (2024-2030)
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Finasteride Segment by Application
1.3.1 Global Finasteride Market Value by Application: (2024-2030)
1.3.2 Medical Uses
1.3.3 Application 2
1.4 Global Finasteride Market Size Estimates and Forecasts
1.4.1 Global Finasteride Revenue 2019-2030
1.4.2 Global Finasteride Sales 2019-2030
1.4.3 Global Finasteride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Finasteride Market Competition by Manufacturers
2.1 Global Finasteride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Finasteride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Finasteride Average Price by Manufacturers (2019-2024)
2.4 Global Finasteride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Finasteride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Finasteride, Product Type & Application
2.7 Finasteride Market Competitive Situation and Trends
2.7.1 Finasteride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Finasteride Players Market Share by Revenue
2.7.3 Global Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Finasteride Retrospective Market Scenario by Region
3.1 Global Finasteride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Finasteride Global Finasteride Sales by Region: 2019-2030
3.2.1 Global Finasteride Sales by Region: 2019-2024
3.2.2 Global Finasteride Sales by Region: 2025-2030
3.3 Global Finasteride Global Finasteride Revenue by Region: 2019-2030
3.3.1 Global Finasteride Revenue by Region: 2019-2024
3.3.2 Global Finasteride Revenue by Region: 2025-2030
3.4 North America Finasteride Market Facts & Figures by Country
3.4.1 North America Finasteride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Finasteride Sales by Country (2019-2030)
3.4.3 North America Finasteride Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Finasteride Market Facts & Figures by Country
3.5.1 Europe Finasteride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Finasteride Sales by Country (2019-2030)
3.5.3 Europe Finasteride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Finasteride Market Facts & Figures by Country
3.6.1 Asia Pacific Finasteride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Finasteride Sales by Country (2019-2030)
3.6.3 Asia Pacific Finasteride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Finasteride Market Facts & Figures by Country
3.7.1 Latin America Finasteride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Finasteride Sales by Country (2019-2030)
3.7.3 Latin America Finasteride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Finasteride Market Facts & Figures by Country
3.8.1 Middle East and Africa Finasteride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Finasteride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Finasteride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Finasteride Sales by Type (2019-2030)
4.1.1 Global Finasteride Sales by Type (2019-2024)
4.1.2 Global Finasteride Sales by Type (2025-2030)
4.1.3 Global Finasteride Sales Market Share by Type (2019-2030)
4.2 Global Finasteride Revenue by Type (2019-2030)
4.2.1 Global Finasteride Revenue by Type (2019-2024)
4.2.2 Global Finasteride Revenue by Type (2025-2030)
4.2.3 Global Finasteride Revenue Market Share by Type (2019-2030)
4.3 Global Finasteride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Finasteride Sales by Application (2019-2030)
5.1.1 Global Finasteride Sales by Application (2019-2024)
5.1.2 Global Finasteride Sales by Application (2025-2030)
5.1.3 Global Finasteride Sales Market Share by Application (2019-2030)
5.2 Global Finasteride Revenue by Application (2019-2030)
5.2.1 Global Finasteride Revenue by Application (2019-2024)
5.2.2 Global Finasteride Revenue by Application (2025-2030)
5.2.3 Global Finasteride Revenue Market Share by Application (2019-2030)
5.3 Global Finasteride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Finasteride Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Actavis
6.2.1 Actavis Corporation Information
6.2.2 Actavis Description and Business Overview
6.2.3 Actavis Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Actavis Finasteride Product Portfolio
6.2.5 Actavis Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Finasteride Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Corporation Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceuticals Finasteride Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Finasteride Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 RelonChem
6.6.1 RelonChem Corporation Information
6.6.2 RelonChem Description and Business Overview
6.6.3 RelonChem Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 RelonChem Finasteride Product Portfolio
6.6.5 RelonChem Recent Developments/Updates
6.7 Dr. Reddy
6.6.1 Dr. Reddy Corporation Information
6.6.2 Dr. Reddy Description and Business Overview
6.6.3 Dr. Reddy Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy Finasteride Product Portfolio
6.7.5 Dr. Reddy Recent Developments/Updates
6.8 Accord Pharmaceuticals
6.8.1 Accord Pharmaceuticals Corporation Information
6.8.2 Accord Pharmaceuticals Description and Business Overview
6.8.3 Accord Pharmaceuticals Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Accord Pharmaceuticals Finasteride Product Portfolio
6.8.5 Accord Pharmaceuticals Recent Developments/Updates
6.9 Henan Topfond
6.9.1 Henan Topfond Corporation Information
6.9.2 Henan Topfond Description and Business Overview
6.9.3 Henan Topfond Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Henan Topfond Finasteride Product Portfolio
6.9.5 Henan Topfond Recent Developments/Updates
6.10 Zhejiang CONBA Pharmaceutical
6.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
6.10.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
6.10.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio
6.10.5 Zhejiang CONBA Pharmaceutical Recent Developments/Updates
6.11 Shandong Renhetang Pharmaceutical
6.11.1 Shandong Renhetang Pharmaceutical Corporation Information
6.11.2 Shandong Renhetang Pharmaceutical Finasteride Description and Business Overview
6.11.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio
6.11.5 Shandong Renhetang Pharmaceutical Recent Developments/Updates
6.12 Guangdong Eashu Pharmacetical
6.12.1 Guangdong Eashu Pharmacetical Corporation Information
6.12.2 Guangdong Eashu Pharmacetical Finasteride Description and Business Overview
6.12.3 Guangdong Eashu Pharmacetical Finasteride Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio
6.12.5 Guangdong Eashu Pharmacetical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Finasteride Industry Chain Analysis
7.2 Finasteride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Finasteride Production Mode & Process
7.4 Finasteride Sales and Marketing
7.4.1 Finasteride Sales Channels
7.4.2 Finasteride Distributors
7.5 Finasteride Customers
8 Finasteride Market Dynamics
8.1 Finasteride Industry Trends
8.2 Finasteride Market Drivers
8.3 Finasteride Market Challenges
8.4 Finasteride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Finasteride Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Finasteride Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Finasteride Market Competitive Situation by Manufacturers in 2023
Table 4. Global Finasteride Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Finasteride Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Finasteride Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Finasteride Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Finasteride Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Finasteride, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Finasteride, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Finasteride, Product Type & Application
Table 12. Global Key Manufacturers of Finasteride, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Finasteride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Finasteride as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Finasteride Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Finasteride Sales by Region (2019-2024) & (MT)
Table 18. Global Finasteride Sales Market Share by Region (2019-2024)
Table 19. Global Finasteride Sales by Region (2025-2030) & (MT)
Table 20. Global Finasteride Sales Market Share by Region (2025-2030)
Table 21. Global Finasteride Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Finasteride Revenue Market Share by Region (2019-2024)
Table 23. Global Finasteride Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Finasteride Revenue Market Share by Region (2025-2030)
Table 25. North America Finasteride Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Finasteride Sales by Country (2019-2024) & (MT)
Table 27. North America Finasteride Sales by Country (2025-2030) & (MT)
Table 28. North America Finasteride Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Finasteride Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Finasteride Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Finasteride Sales by Country (2019-2024) & (MT)
Table 32. Europe Finasteride Sales by Country (2025-2030) & (MT)
Table 33. Europe Finasteride Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Finasteride Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Finasteride Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Finasteride Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Finasteride Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Finasteride Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Finasteride Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Finasteride Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Finasteride Sales by Country (2019-2024) & (MT)
Table 42. Latin America Finasteride Sales by Country (2025-2030) & (MT)
Table 43. Latin America Finasteride Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Finasteride Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Finasteride Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Finasteride Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Finasteride Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Finasteride Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Finasteride Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Finasteride Sales (MT) by Type (2019-2024)
Table 51. Global Finasteride Sales (MT) by Type (2025-2030)
Table 52. Global Finasteride Sales Market Share by Type (2019-2024)
Table 53. Global Finasteride Sales Market Share by Type (2025-2030)
Table 54. Global Finasteride Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Finasteride Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Finasteride Revenue Market Share by Type (2019-2024)
Table 57. Global Finasteride Revenue Market Share by Type (2025-2030)
Table 58. Global Finasteride Price (USD/Kg) by Type (2019-2024)
Table 59. Global Finasteride Price (USD/Kg) by Type (2025-2030)
Table 60. Global Finasteride Sales (MT) by Application (2019-2024)
Table 61. Global Finasteride Sales (MT) by Application (2025-2030)
Table 62. Global Finasteride Sales Market Share by Application (2019-2024)
Table 63. Global Finasteride Sales Market Share by Application (2025-2030)
Table 64. Global Finasteride Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Finasteride Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Finasteride Revenue Market Share by Application (2019-2024)
Table 67. Global Finasteride Revenue Market Share by Application (2025-2030)
Table 68. Global Finasteride Price (USD/Kg) by Application (2019-2024)
Table 69. Global Finasteride Price (USD/Kg) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. Merck Finasteride Product
Table 74. Merck Recent Developments/Updates
Table 75. Actavis Corporation Information
Table 76. Actavis Description and Business Overview
Table 77. Actavis Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. Actavis Finasteride Product
Table 79. Actavis Recent Developments/Updates
Table 80. Sandoz Corporation Information
Table 81. Sandoz Description and Business Overview
Table 82. Sandoz Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Sandoz Finasteride Product
Table 84. Sandoz Recent Developments/Updates
Table 85. Teva Pharmaceuticals Corporation Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Teva Pharmaceuticals Finasteride Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Cipla Corporation Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. Cipla Finasteride Product
Table 94. Cipla Recent Developments/Updates
Table 95. RelonChem Corporation Information
Table 96. RelonChem Description and Business Overview
Table 97. RelonChem Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. RelonChem Finasteride Product
Table 99. RelonChem Recent Developments/Updates
Table 100. Dr. Reddy Corporation Information
Table 101. Dr. Reddy Description and Business Overview
Table 102. Dr. Reddy Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Dr. Reddy Finasteride Product
Table 104. Dr. Reddy Recent Developments/Updates
Table 105. Accord Pharmaceuticals Corporation Information
Table 106. Accord Pharmaceuticals Description and Business Overview
Table 107. Accord Pharmaceuticals Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. Accord Pharmaceuticals Finasteride Product
Table 109. Accord Pharmaceuticals Recent Developments/Updates
Table 110. Henan Topfond Corporation Information
Table 111. Henan Topfond Description and Business Overview
Table 112. Henan Topfond Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 113. Henan Topfond Finasteride Product
Table 114. Henan Topfond Recent Developments/Updates
Table 115. Zhejiang CONBA Pharmaceutical Corporation Information
Table 116. Zhejiang CONBA Pharmaceutical Description and Business Overview
Table 117. Zhejiang CONBA Pharmaceutical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 118. Zhejiang CONBA Pharmaceutical Finasteride Product
Table 119. Zhejiang CONBA Pharmaceutical Recent Developments/Updates
Table 120. Shandong Renhetang Pharmaceutical Corporation Information
Table 121. Shandong Renhetang Pharmaceutical Description and Business Overview
Table 122. Shandong Renhetang Pharmaceutical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 123. Shandong Renhetang Pharmaceutical Finasteride Product
Table 124. Shandong Renhetang Pharmaceutical Recent Developments/Updates
Table 125. Guangdong Eashu Pharmacetical Corporation Information
Table 126. Guangdong Eashu Pharmacetical Description and Business Overview
Table 127. Guangdong Eashu Pharmacetical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 128. Guangdong Eashu Pharmacetical Finasteride Product
Table 129. Guangdong Eashu Pharmacetical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Finasteride Distributors List
Table 133. Finasteride Customers List
Table 134. Finasteride Market Trends
Table 135. Finasteride Market Drivers
Table 136. Finasteride Market Challenges
Table 137. Finasteride Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Finasteride
Figure 2. Global Finasteride Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Finasteride Market Share by Type in 2023 & 2030
Figure 4. 1mg Tablet Product Picture
Figure 5. 5mg Tablet Product Picture
Figure 6. Global Finasteride Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Finasteride Market Share by Application in 2023 & 2030
Figure 8. Medical Uses
Figure 9. Application 2
Figure 10. Global Finasteride Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Finasteride Market Size (2019-2030) & (US$ Million)
Figure 12. Global Finasteride Sales (2019-2030) & (MT)
Figure 13. Global Finasteride Average Price (USD/Kg) & (2019-2030)
Figure 14. Finasteride Report Years Considered
Figure 15. Finasteride Sales Share by Manufacturers in 2023
Figure 16. Global Finasteride Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Finasteride Players: Market Share by Revenue in 2023
Figure 18. Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Finasteride Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Finasteride Sales Market Share by Country (2019-2030)
Figure 21. North America Finasteride Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Finasteride Sales Market Share by Country (2019-2030)
Figure 25. Europe Finasteride Revenue Market Share by Country (2019-2030)
Figure 26. Germany Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Finasteride Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Finasteride Revenue Market Share by Region (2019-2030)
Figure 33. China Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Finasteride Sales Market Share by Country (2019-2030)
Figure 44. Latin America Finasteride Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Finasteride Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Finasteride Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Finasteride Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Finasteride by Type (2019-2030)
Figure 54. Global Revenue Market Share of Finasteride by Type (2019-2030)
Figure 55. Global Finasteride Price (USD/Kg) by Type (2019-2030)
Figure 56. Global Sales Market Share of Finasteride by Application (2019-2030)
Figure 57. Global Revenue Market Share of Finasteride by Application (2019-2030)
Figure 58. Global Finasteride Price (USD/Kg) by Application (2019-2030)
Figure 59. Finasteride Value Chain
Figure 60. Finasteride Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’